Pci Biotech Holding Stock Filter Stocks by Fundamentals
PCIB Stock | NOK 1.65 0.05 3.12% |
PCI Biotech Holding fundamentals help investors to digest information that contributes to PCI Biotech's financial success or failures. It also enables traders to predict the movement of PCI Stock. The fundamental analysis module provides a way to measure PCI Biotech's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to PCI Biotech stock.
PCI |
Did you try this?
Run Headlines Timeline Now
Headlines TimelineStay connected to all market stories and filter out noise. Drill down to analyze hype elasticity |
All Next | Launch Module |
PCI Fundamentals
Return On Equity | -0.74 | |||
Return On Asset | -0.4 | |||
Operating Margin | (15.29) % | |||
Current Valuation | 25.47 M | |||
Shares Outstanding | 37.33 M | |||
Shares Owned By Insiders | 31.97 % | |||
Shares Owned By Institutions | 6.90 % | |||
Price To Earning | (10.88) X | |||
Price To Book | 1.44 X | |||
Price To Sales | 18.74 X | |||
Revenue | 6.27 M | |||
Gross Profit | 6.27 M | |||
EBITDA | (85.76 M) | |||
Net Income | (88.39 M) | |||
Cash And Equivalents | 116.12 M | |||
Cash Per Share | 8.83 X | |||
Total Debt | 1.28 M | |||
Debt To Equity | 0.50 % | |||
Current Ratio | 16.24 X | |||
Book Value Per Share | 1.70 X | |||
Cash Flow From Operations | (68.31 M) | |||
Earnings Per Share | (2.35) X | |||
Target Price | 24.0 | |||
Number Of Employees | 14 | |||
Beta | 1.86 | |||
Market Capitalization | 81.93 M | |||
Total Asset | 135.98 M | |||
Working Capital | 38 M | |||
Current Asset | 48 M | |||
Current Liabilities | 10 M | |||
Z Score | 38.4 | |||
Net Asset | 135.98 M |
About PCI Biotech Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze PCI Biotech Holding's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of PCI Biotech using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of PCI Biotech Holding based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards PCI Biotech in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, PCI Biotech's short interest history, or implied volatility extrapolated from PCI Biotech options trading.
Becoming a Better Investor with Macroaxis
Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as PCI Biotech Holding using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.Build Optimal Portfolios
Align your risk with return expectations
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in PCI Biotech Holding. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.
Complementary Tools for PCI Stock analysis
When running PCI Biotech's price analysis, check to measure PCI Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy PCI Biotech is operating at the current time. Most of PCI Biotech's value examination focuses on studying past and present price action to predict the probability of PCI Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move PCI Biotech's price. Additionally, you may evaluate how the addition of PCI Biotech to your portfolios can decrease your overall portfolio volatility.
CEOs Directory Screen CEOs from public companies around the world | |
Share Portfolio Track or share privately all of your investments from the convenience of any device | |
Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
Stocks Directory Find actively traded stocks across global markets | |
Transaction History View history of all your transactions and understand their impact on performance | |
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
Global Correlations Find global opportunities by holding instruments from different markets |